(ANDE) The Andersons - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0341641035

ANDE: Grain, Ethanol, Fertilizer, Commodities, Nutrients, Products

The Andersons, Inc. (NASDAQ:ANDE) is a diversified company with a strong presence in the agricultural and industrial sectors, operating across multiple countries including the U.S., Canada, Mexico, Egypt, Switzerland, and others. With a market capitalization of approximately $1.4 billion, the company is structured into three core segments: Trade, Renewables, and Nutrient & Industrial. This diversification allows it to balance risk and capitalize on opportunities across different markets.

The Trade segment is the backbone of the company, focusing on grain elevators, commodity storage, and marketing. It trades a wide range of commodities such as corn, soybeans, wheat, and ethanol, while also providing logistics and risk management services. This segment essentially acts as a critical link between producers and end-users, ensuring efficient flow of agricultural commodities. The Renewables segment builds on this by producing and selling ethanol, a key biofuel, along with co-products. By integrating its ethanol operations with its trade business, the company optimizes its supply chain and reduces transportation costs.

The Nutrient & Industrial segment rounds out the companys offerings, manufacturing and distributing agricultural fertilizers, industrial products, and specialty items like corncob-based products. This segment serves both farmers and industrial clients, providing essential nutrients for crops and raw materials for various industries. The companys ability to produce everything from turf fertilizers to deicers and dust abatement products highlights its versatility and deep understanding of its markets.

For investors, The Andersons, Inc. presents an interesting case. Its trailing P/E of 11.81 and forward P/E of 20.92 suggest expectations of growth, though the premium valuation may raise questions about near-term catalysts. The P/S ratio of 0.12 indicates modest revenue generation relative to its market cap, while the P/B ratio

Additional Sources for ANDE Stock

ANDE Stock Overview

Market Cap in USD 1,468m
Sector Consumer Defensive
Industry Food Distribution
GiC Sub-Industry Food Distributors
IPO / Inception 1996-02-20

ANDE Stock Ratings

Growth 5y 49.1%
Fundamental 4.69%
Dividend 54.7%
Rel. Strength Industry -26.1
Analysts 5/5
Fair Price Momentum 44.73 USD
Fair Price DCF 123.81 USD

ANDE Dividends

Dividend Yield 12m 2.13%
Yield on Cost 5y 6.86%
Annual Growth 5y -4.03%
Payout Consistency 99.2%

ANDE Growth Ratios

Growth Correlation 3m 15.1%
Growth Correlation 12m -88.2%
Growth Correlation 5y 87.5%
CAGR 5y 24.49%
CAGR/Max DD 5y 0.50
Sharpe Ratio 12m -0.84
Alpha -27.36
Beta 0.48
Volatility 38.58%
Current Volume 230.6k
Average Volume 20d 297.1k
What is the price of ANDE stocks?
As of March 15, 2025, the stock is trading at USD 41.91 with a total of 230,635 shares traded.
Over the past week, the price has changed by -2.83%, over one month by +3.35%, over three months by -3.79% and over the past year by -20.04%.
Is The Andersons a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, The Andersons is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ANDE as of March 2025 is 44.73. This means that ANDE is currently overvalued and has a potential downside of 6.73%.
Is ANDE a buy, sell or hold?
The Andersons has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy ANDE.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ANDE stock price target?
According to ValueRays Forecast Model, ANDE The Andersons will be worth about 48.3 in March 2026. The stock is currently trading at 41.91. This means that the stock has a potential upside of +15.27%.
Issuer Forecast Upside
Wallstreet Target Price 62.5 49.1%
Analysts Target Price 65 55.1%
ValueRay Target Price 48.3 15.3%